Answers are grounded in this paper and cite their sources.
RAS mutation predicts early lung recurrence and worse survival after curative resection of CLM. This information may be used to individualize systemic and local tumor-directed therapies and follow-up strategies.
No takes yet. Share an insight, caveat, or question.
Vauthey et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: